| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.083 | 0.03 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.17 | 0.03 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.57 | 0.03 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.04 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.04 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.04 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.04 |